BIA MEP Brexit briefing, June 2019

Medicines Discovery Catapult has appointed Dr Mike Strange as its Chief Executive Officer.

Poolbeg Pharma announces its unaudited interim results for the six months to 30 June 2026.

Global drug development consultancy Boyds has strengthened its Regulatory Affairs team with the appointment of two senior specialists.

£135 million for two life sciences funds, rare disease R&D, Beacon Therapeutics, Basecamp Research’s Series C, Birmingham Life Sciences Week, Liberal Democrat party conference, Women in Biotech Edinburgh

To mark World Cancer Research Day, we are proud to share this film celebrating innovation in immunotherapy, the passion of our team working together in scientific discovery and our shared goal of developing new approaches for patients with cancer.